Two Sigma Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-119,312
| Closed | -$445K | – | 3518 |
|
2024
Q3 | $445K | Sell |
119,312
-14,632
| -11% | -$54.6K | ﹤0.01% | 2461 |
|
2024
Q2 | $750K | Sell |
133,944
-29,491
| -18% | -$165K | ﹤0.01% | 2079 |
|
2024
Q1 | $856K | Sell |
163,435
-44,179
| -21% | -$231K | ﹤0.01% | 1988 |
|
2023
Q4 | $1.09M | Buy |
207,614
+174,934
| +535% | +$915K | ﹤0.01% | 1951 |
|
2023
Q3 | $515K | Buy |
32,680
+3,576
| +12% | +$56.4K | ﹤0.01% | 2192 |
|
2023
Q2 | $566K | Buy |
+29,104
| New | +$566K | ﹤0.01% | 2208 |
|
2021
Q2 | – | Sell |
-127,206
| Closed | -$5.31M | – | 2990 |
|
2021
Q1 | $5.31M | Buy |
127,206
+21,524
| +20% | +$898K | 0.01% | 803 |
|
2020
Q4 | $4.92M | Buy |
105,682
+53,409
| +102% | +$2.49M | 0.01% | 742 |
|
2020
Q3 | $2.22M | Buy |
52,273
+17,509
| +50% | +$744K | 0.01% | 880 |
|
2020
Q2 | $1.67M | Buy |
+34,764
| New | +$1.67M | 0.01% | 949 |
|
2019
Q2 | – | Sell |
-97,049
| Closed | -$4.9M | – | 2505 |
|
2019
Q1 | $4.9M | Buy |
97,049
+3,789
| +4% | +$191K | 0.02% | 818 |
|
2018
Q4 | $3.76M | Buy |
+93,260
| New | +$3.76M | 0.01% | 826 |
|
2018
Q3 | – | Sell |
-47,901
| Closed | -$3.62M | – | 2426 |
|
2018
Q2 | $3.62M | Buy |
+47,901
| New | +$3.62M | 0.01% | 833 |
|
2017
Q1 | – | Sell |
-33,437
| Closed | -$2.65M | – | 2496 |
|
2016
Q4 | $2.65M | Buy |
+33,437
| New | +$2.65M | 0.01% | 1010 |
|
2016
Q2 | – | Sell |
-9,300
| Closed | -$377K | – | 2388 |
|
2016
Q1 | $377K | Sell |
9,300
-8,924
| -49% | -$362K | ﹤0.01% | 1698 |
|
2015
Q4 | $1.62M | Sell |
18,224
-72,646
| -80% | -$6.44M | 0.01% | 1038 |
|
2015
Q3 | $6.73M | Buy |
90,870
+48,544
| +115% | +$3.59M | 0.03% | 436 |
|
2015
Q2 | $3.42M | Sell |
42,326
-4,679
| -10% | -$378K | 0.02% | 831 |
|
2015
Q1 | $1.97M | Buy |
+47,005
| New | +$1.97M | 0.01% | 1084 |
|